Using drama to teach about breast and gynecological cancers
Part of Women’s health & pregnancy clinical trials.
This study teaches midwifery students about breast and gynecological cancers using creative drama activities. It aims to see if drama helps students learn more about these cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a midwifery student.
- You are between 18 and 35 years old.
- You are in good health (no ongoing health problems).
- You are willing to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether teaching with creative drama based on Leininger's theory helps nursing students become more culturally sensitive and effective. If you are a nursing student who has taken intercultural nursing and most clinical courses, you may be able to join.
This trial explores how creative drama education affects student nurses' professional values. It is a study, not a treatment, and may help improve nursing education.
This study tests if creative drama and game-based lessons help 10 to 12-year-olds learn about healthy eating. It might be a fun way to build good habits.
This study tests whether creative drama activities can help nursing students become more culturally competent. It is open to senior nursing students who have a lower-than-average score on a cultural awareness test and have not had previous training in this area.
This study tests if creative drama activities help first-year nursing students understand nursing theories. It may help you learn in a more engaging way.
This study tests a creative drama program designed to help students learn how to step in when they see bullying. It aims to increase empathy and give students tools to safely intervene.
Hear when a new Creative Drama trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.